Cancer Biomarkers

Cancer biomarkers, particular those associated with genetic mutations or epigenetic alterations, often offer a quantitative way to determine when individuals are predisposed to particular types of cancers. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology.

  • Biomarkers in cancer research
  • Biomarkers in medicine
  • Risk assessment, diagnosis
  • Prognosis and treatment predictions
  • Molecular cancer biomarkers

 

    Related Conference of Cancer Biomarkers

    November 18-19, 2019

    World Congress on Histopathology

    Berlin, Germany
    December 02-03, 2019

    International Conference on Virology & bacteriology

    Manila, Philippines
    January 16-17, 2020

    International conference on Pediatric Pathology

    Lisbon, Portugal
    February 12-13, 2020

    2nd International Conference on Molecular Pathology

    Paris | France
    April 13-14, 2020 |

    11thInternational Conference on Chemistry

    Zagreb, Croatia
    April 29-30, 2020

    18th European Pathology Congress

    Prague, Czech Republic

    International Conference on Surgical Pathology

    Holiday Inn Amsterdam - Arena Towers,Amsterdam,Netherlands
    September 07-08, 2020 -

    2nd World Neonatology and Child Care Meeting

    Prague, Czech Republic

    Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in